Novartis Investigative Site

Mid Glamorgan CF484DR

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Cystic Fibrosis

Studies at this site

• Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients — Stopped early
• Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age — Completed